JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (2): 16-20.doi: 10.6040/j.issn.1671-7554.0.2015.829

Previous Articles     Next Articles

Inducible nitric oxide synthase contributes to the delayed cardioprotection of ischemic postconditioning in rats

LI Xin1*, WANG Gongming1*, WANG Hong2, WANG Yan1, ZHANG Ligong1, ZHANG Le1, LIU Bei1, ZHANG Mengyuan1   

  1. 1. Department of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China;
    2. Department of Nephrology, Taian Central Hospital, Taian 271000, Shandong, China
  • Received:2015-09-01 Online:2016-02-10 Published:2016-02-10

Abstract: Objective To investigate the delayed cardioprotective effects of ischemic preconditioning(IPO)and the role of inducible nitric oxide synthase(iNOS)in the late phase of IPO. Methods A total of 160 rats were randomized into 5 groups: I/R group, IPO group, IPO+1400W(iNOS inhibitor)group, I/R+1400W group and sham-operated(sham)group. Animals in each group received 3, 24, 48 or 72 h of reperfusion after ischemia(n=8 per each time point). Cardio-infarct size and creatine kinase(CK)activity were measured respectively. Western blotting was used to assess the expressions of phosphorylated endothelial nitric oxide synthase(p-eNOS)and iNOS in the heart. Results At reperfusion 3 h, in the IPO group, the infarct size of left ventricle(LV)decreased significantly compared with I/R group[(18.0±2.3)% vs(30.7±3.1)%, P<0.05). At reperfusion 72 h, the difference between IPO group and I/R group in infarct size was obvious[(25.7±1.1)% vs(34.9±0.8)%, P<0.05]. Difference in the CK activity was positively correlated with the difference in infarct size in all groups. IPO increased p-eNOS levels at R 3 h and R 24 h 山 东 大 学 学 报 (医 学 版)54卷2期 -李欣,等.诱导型一氧化氮合成酶参与大鼠心脏缺血后处理延迟相的保护作用 \=-and iNOS levels at R 48 h and R 72 h. Conclusion IPO has delayed cardioprotective effects on myocardial infarction, and iNOS plays a critical role in the delayed effects against heart injury.

Key words: Ischemic postconditioning, Ischemia-reperfusion injury, Endothelial nitric oxide synthase, Inducible nitric oxide synthase, Delayed cardioprotective effect

CLC Number: 

  • R654
[1] Forouzanfar MH, Moran AE, Flaxman AD, et al. Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010[J]. Glob Heart, 2012, 7(4): 331-342.
[2] Domburg RT, Hendriks JM, Kamp O, et al. Three life years gained after reperfusion therapy in acute myocardial infarction: 25-30 years after a randomized controlled trial[J]. Eur J Prev Cardiol, 2012, 19(6): 1316-1323.
[3] Gross GJ, Auchampach JA. Reperfusion injury: does it exist?[J]. J Mol Cell Cardiol, 2007, 42(1): 12-18.
[4] Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium[J]. Circulation, 1986, 74(5): 1124-1136.
[5] Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning[J]. Am J Physiol Heart Circ Physiol, 2003, 285(2): 579-588.
[6] Bousselmi R, Lebbi MA, Ferjani M. Myocardial ischemic conditioning: physiological aspects and clinical applications in cardiac surgery[J]. J Saudi Heart Assoc, 2014, 26(2): 93-100.
[7] Tawa M, Fukumoto T, Yamashita N, et al. Postconditioning improves postischemic cardiac dysfunction independently of norepinephrine overflow after reperfusion in rat hearts: comparison with preconditioning[J]. J Cardiovasc Pharmacol, 2010, 55(1): 6-13.
[8] Zhang GM, Wang Y, Li TD, et al. Post-conditioning with gradually increased reperfusion provides better cardioprotection in rats[J]. World J Emerg Med, 2014, 5(2):128-134.
[9] 陈冰心, 任澎, 段明军, 等. 大鼠心肌缺血再灌注模型构建的改良[J]. 中国比较医学杂志, 2010, 20(5): 24-28. CHEN Bingxin, REN Peng, DUAN Mingjun, et al. Improvement of establishing a myocardial ischemic reperfusion model in rats[J]. Chinese Journal of Comparative Medicine, 2010, 20(5): 24-28.
[10] Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures[J]. Am J Physiol Heart Circ Physiol, 2011, 301(5): 1723-1741.
[11] Argaud L, Gateau-Roesch O, Raisky O, et al. Postconditioning inhibits mitochondrial permeability transition[J]. Circulation, 2005, 111(2): 194-197.
[12] Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury[J]. Cardiovasc Res, 2006, 70(2): 200-211.
[13] Zhao ZQ, Velez DA, Wang NP, et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion[J]. Apoptosis, 2001, 6(4): 279-290.
[14] Mykytenko J, Kerendi F, Reeves JG, et al. Long-term inhibition of myocardial infarction by postconditioning during reperfusion[J]. Basic Res Cardiol, 2007, 102(1): 90-100.
[15] Granfeldt A. Organ dysfunction following regional and global ischemia/reperfusion. Intervention with postconditioning and adenocaine[J]. Danish Med J, 2012, 59(8): 4496.
[16] Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning[J]. Trends Cardiovasc Med, 2005, 15(2): 69-75.
[17] Jones WK, Flaherty MP, Tang XL, et al. Ischemic preconditioning increases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism[J]. J Mol Cell Cardiol, 1999, 31(8): 1469-1481.
[18] Guo Y, Jones WK, Xuan YT, et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene[J]. Proc Natl Acad Sci U S A, 1999, 96(20): 11507-11512.
[19] Ertracht O, Malka A, Atar S, et al. The mitochondria as a target for cardioprotection in acute myocardial ischemia[J]. J Pharmacol Exp Ther, 2014, 142(1): 33-40.
[20] Hausenloy DJ, Ong SB, Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning[J]. Basic Res Cardiol, 2009, 104(2): 189-202.
[21] Ohtani H, Katoh H, Tanaka T, et al. Effects of nitric oxide on mitochondrial permeability transition pore and thiol-mediated responses in cardiac myocytes[J]. Nitric Oxide, 2012, 26(2): 95-101.
[22] Beresewicz A. Endogenous cardioprotective mechanisms-what is it about and how does it work?[J]. Kardiol Pol, 2011, 69(3): 59-66.
[1] LIU Fang, QIAO Lei, CHEN Wenchao, YANG Lina. Cardioprotective effects of allicin postconditioning on myocardial ischemia-reperfusion injury in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 6-11.
[2] LIANG Lining, ZHONG Xia, JI Xianfei, HU Haoran, ZHU Fangfang, CHEN Jibin,CHEN Qianqian, SHANG Deya. Protective effects of post-conditioning with nicorandil on myocardial, cerebral and renal ischemia-reperfusion injury following cardiac arrest in swine [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 46-51.
[3] HU Haoran, YUAN Meng, LIANG Lining, JI Xianfei, LI Tao, CHEN Yong, LIU Fuli, BIAN Hongjun, ZHOU Yi, HU Bo, ZHONG Xia, SHANG Deya. Effect of the cycle time of myocardial ischemic postconditioning on patients undergoing primary percutaneous coronary intervention [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 57-62.
[4] LIU Shan-wen1, WANG Fu1, LI Bin2, GENG Hai-hua3, LI Cai-e4, XU Zhe5, LI Rui1, XIAO Jie1, ZHANG Sen1, JI Xiao-ping1. Isolation of rat bone marrow mesenchymal stem cell-derived exosome and the uptake of exosome by H9C2 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 1-7.
[5] DING Ming1, ZONG Bo1, WANG Xue-ping2. Protective mechanisms of fentanil and methylprednisolone sodium succinate
on ischemia-reperfusion injury after rabbit limb replantation
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 55-58.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!